Sildenafil Citrate Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2020 - 2025

Report Code: HCR 68774 Report Format: PDF + Excel (Delivery in 48 Hrs)
Sildenafil Citrate Market size is forecast to reach $1.79 billion by 2025, growing at a CAGR of 5.8% during the forecast period 2020-2025. Sildenafil, sold under the brand name Viagra among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. It is unclear if it is effective for treating sexual dysfunction in women. It is taken by mouth or injection into a vein. It belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum, but enhances the effect of nitric oxide (NO) by inhibiting phosphodiesterase type 5 (PDE5), which is responsible for degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. Sildenafil is also used in both men and women to treat the symptoms of pulmonary arterial hypertension. This is a type of high blood pressure that occurs between the heart and the lungs. Growing prevalence of erectile dysfunction owing to harmful lifestyle, rising public awareness about health and sex related problems, rapid product developments by key market players and increasing initiatives by government and NGOs for awareness and treatment campaigns of sex related disorders are driving the market growth in recent years. In addition, major product launches of key players like Lupin Limited are other factors driving the growth of the market. 

Report Coverage
The report: “Sildenafil Citrate Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Sildenafil Citrate Market. 

By Product Type: 25 mg Tablets, 50 mg Tablets, 100 mg Tablets
By Application Type: Medical Uses, Non-Medical Uses
By Disorders: Erectile Dysfunction, Angina Pectoris, Pulmonary Hypertension, Others
By Geography: North America, Europe, Asia-Pacific, Rest of the World (RoW)

Key Takeaways
  • North America dominated the Sildenafil Citrate Market in the year 2019 owing to growing prevalence of erectile dysfunction, increasing incidences of diabetes and other chronic diseases and changing lifestyle standards. The Sildenafil Citrate Market scope for different regions will be provided in the final report.
  • Changing lifestyle and habits of majority of population, increased awareness about sex related disorders and technological innovations in development of Sildenafil Citrate and related drugs by key market companies have helped in significant growth of Sildenafil Citrate Market. 
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market ` be provided in the Sildenafil Citrate Market report.
  • Presence of alternatives like Tadalafil and Vardenafil are anticipated to hamper the market growth of the Sildenafil Citrate Industry.

Application Type - Segment Analysis
Medical uses held the largest share in the application type segment of Sildenafil Citrate Market in 2019 and is estimated to grow at a CAGR of 6.27% during the forecast period 2020-2025. Sildenafil (Revatio) is used to improve the ability to exercise in adults with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). In recent years, prescription by doctors and more advancement in medications with efficiency and advantages for consumers has resulted in the growth of medical uses of Sildenafil. Non-Medical uses held the second largest share in 2019. Viagra can reduce pulmonary artery pressure at high altitude and improve the ability to exercise in low oxygen conditions. In affected individuals, exposure to the cold triggers spasm of the small arteries that supply blood to the fingers, toes, or both, which become pale, cold, and painful. Medical uses is set to be the fastest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025, owing to increasing investments in innovations of medical applications of Sildenafil drug by key market players.

Disorder Type - Segment Analysis
Erectile Dysfunction holds the major share in the disorders segment of Sildenafil Citrate Market in 2019. About 5 percent of men that are 40 years old have complete erectile dysfunction, and that number increases to about 15 percent of men at age 70. Mild and moderate erectile dysfunction affects approximately 10 percent of men per decade of life (i.e., 50 percent of men in their 50s, 60 percent of men in their 60s). In accordance with increasing awareness, people are opting for drugs and other medications, which drives the market growth. Erectile Dysfunction is forecast to continue growing at the fastest rate with the highest CAGR during the forecast period 2020-2025, owing to an estimated increase in cases of the disease in upcoming years, and increasing awareness programs for treatment of the disease.

Geography - Segment Analysis
North America dominated the geography segment of Sildenafil Citrate Market in 2019 with a share of more than 36.71% in 2019, followed by Europe. Rising incidence of diseases like erectile dysfunction and hypertension, presence of key market players in the region and availability of well-established key market players in this region have helped in the growth of Sildenafil Citrate Market infrastructure. Europe held the second place in the geography segment share of the market, owing to presence of robust healthcare infrastructure and increasing favorable government policies for drug market.

However, Asia-Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025. This is owing to growth of healthcare sector, increasing awareness about treatment of sexual disorders and increasing average income of the masses.

Drivers – Sildenafil Citrate Market
  • Changing lifestyle and habits of majority of population
Poor diet, smoking, sedentary lifestyle, excessive drinking, stress, relationship issues and psychological issues in the modern lifestyle have caused much problems in sexual health of the common person. In order to treat this, the demand for the drug has substantially increased within a few years.
  • Increased awareness about sex related disorders
Sexual desire disorders are under-recognized, under-treated disorders leading to a great deal of morbidity in relationships. Owing to massive awareness campaigns, people are finding easier to talk about their sexual health and disorders. As a result, demand for medications increases and this is projected to drive the Infusion Market growth during the forecast period 2020-2025.

Challenges – Sildenafil Citrate Market
  • Presence of alternatives in the market
Presence of pills, herbal remedies and other medications have taken away a significant chunk of the revenue of Sildenafil in the sexual diseases drugs market. For instance, Vardenafil and Tadalafil are two such drugs which have significantly gained popularity in recent times. It is anticipated to hamper the market growth during the forecast period 2020-2025.

Sildenafil Citrate Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Sildenafil Citrate Market. In 2019, Sildenafil Citrate Market share is consolidated by the top players present in the market. Sildenafil Citrate Market top 10 companies are Aglowmed Pharmaceutical Ltd, Alembic Chemical Work Co. Ltd, Atlas Laboratory Pvt Ltd, H L Healthcare Pvt Ltd, Ind-Swift Limited, Lupin Laboratory Ltd, Ranbaxy Laboratory Ltd, Sun Rise International Lab Ltd, Torrent Pharmaceutical Ltd and Wisdom Pharmaceutical Co., Ltd among others.

Acquisitions/Product Launches
  • In September 2019, Lupin Limited (Lupin) announced the launch of Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.
  • In March 2019, Alembic Pharmaceuticals receives USFDA Approval for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg, which shall help expand the erectile dysfunction medication market in the region.
1. Sildenafil Citrate Market Overview
    1.1 Definitions and Scope
2. Sildenafil Citrate Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Application Type
    2.3 Key trends by Disorders 
    2.4 Key trends by Geography
3. Sildenafil Citrate Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Sildenafil Citrate Market - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Sildenafil Citrate Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Sildenafil Citrate Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Sildenafil Citrate Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Sildenafil Citrate Market – By Product Type (Market Size –$Million/$Billion)
    8.1 25 mg tablets
    8.2 50 mg tablets
    8.3 100 mg tablets
9. Sildenafil Citrate Market – By Application Type (Market Size –$Million/$Billion)
    9.1 Medical Uses
    9.2 Non-Medical Uses
10. Sildenafil Citrate Market – By Disorders (Market Size –$Million/$Billion)
    10.1 Erectile Dysfunction
    10.2 Angina Pectoris
    10.3 Pulmonary Hypertension
    10.4 Others
11. Sildenafil Citrate Market – By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Sildenafil Citrate Market - Entropy
13. Sildenafil Citrate Market – Industry/Segment Competition Landscape   (Premium) 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Sildenafil Citrate Market – Key Company List by Country Premium (Premium)
15. Sildenafil Citrate Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

LIST OF FIGURES

1.US Sildenafil Citrate Market Revenue, 2019-2024 ($M)
2.Canada Sildenafil Citrate Market Revenue, 2019-2024 ($M)
3.Mexico Sildenafil Citrate Market Revenue, 2019-2024 ($M)
4.Brazil Sildenafil Citrate Market Revenue, 2019-2024 ($M)
5.Argentina Sildenafil Citrate Market Revenue, 2019-2024 ($M)
6.Peru Sildenafil Citrate Market Revenue, 2019-2024 ($M)
7.Colombia Sildenafil Citrate Market Revenue, 2019-2024 ($M)
8.Chile Sildenafil Citrate Market Revenue, 2019-2024 ($M)
9.Rest of South America Sildenafil Citrate Market Revenue, 2019-2024 ($M)
10.UK Sildenafil Citrate Market Revenue, 2019-2024 ($M)
11.Germany Sildenafil Citrate Market Revenue, 2019-2024 ($M)
12.France Sildenafil Citrate Market Revenue, 2019-2024 ($M)
13.Italy Sildenafil Citrate Market Revenue, 2019-2024 ($M)
14.Spain Sildenafil Citrate Market Revenue, 2019-2024 ($M)
15.Rest of Europe Sildenafil Citrate Market Revenue, 2019-2024 ($M)
16.China Sildenafil Citrate Market Revenue, 2019-2024 ($M)
17.India Sildenafil Citrate Market Revenue, 2019-2024 ($M)
18.Japan Sildenafil Citrate Market Revenue, 2019-2024 ($M)
19.South Korea Sildenafil Citrate Market Revenue, 2019-2024 ($M)
20.South Africa Sildenafil Citrate Market Revenue, 2019-2024 ($M)
21.North America Sildenafil Citrate By Application
22.South America Sildenafil Citrate By Application
23.Europe Sildenafil Citrate By Application
24.APAC Sildenafil Citrate By Application
25.MENA Sildenafil Citrate By Application
26.Aglowmed Pharmaceutical Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Wisdom Pharmaceutical Co.,Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Ind-Swift Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.H L Healthcare Pvt Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Alembic Chemical Work Co. Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Torrent Pharmaceutical Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Atlas Laboratory Pvt Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Ranbaxy Laboratory Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Sun Rise International Lab Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Lupin Laboratory Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)